Department of Thoracic and Cardiovascular Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Department of Pathology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Medicine (Baltimore). 2022 Oct 21;101(42):e30362. doi: 10.1097/MD.0000000000030362.
It remains challenging to determine the regions of metastasis to lymph nodes during operation for clinical stage I non-small cell lung cancer (NSCLC). This study aimed to establish intraoperative mathematical models with nomograms for predicting the hilar-intrapulmonary node metastasis (HNM) and the mediastinal node metastasis (MNM) in patients with clinical stage I NSCLC. The clinicopathological variables of 585 patients in a derivation cohort who underwent thoracoscopic lobectomy with complete lymph node dissection were retrospectively analyzed for their association with the HNM or the MNM. After analyzing the variables, we developed multivariable logistic models with nomograms to estimate the risk of lymph node metastasis in different regions. The predictive efficacy was then validated in a validation cohort of 418 patients. It was confirmed that carcinoembryonic antigen (>5.75 ng/mL), CYFRA211 (>2.85 ng/mL), the maximum diameter of tumor (>2.75 cm), tumor differentiation (grade III), bronchial mucosa and cartilage invasion, and vascular invasion were predictors of HNM, and carcinoembryonic antigen (>8.25 ng/mL), CYFRA211 (>2.95 ng/mL), the maximum diameter of tumor (>2.75 cm), tumor differentiation (grade III), bronchial mucosa and cartilage invasion, vascular invasion, and visceral pleural invasion were predictors of MNM. The validation of the prediction models based on the above results demonstrated good discriminatory power. Our predictive models are helpful in the decision-making process of specific therapeutic strategies for the regional lymph node metastasis in patients with clinical stage I NSCLC.
在临床 I 期非小细胞肺癌(NSCLC)手术中,确定淋巴结转移区域仍然具有挑战性。本研究旨在建立用于预测临床 I 期 NSCLC 患者肺门-肺内淋巴结转移(HNM)和纵隔淋巴结转移(MNM)的术中数学模型和列线图。回顾性分析了 585 例接受电视胸腔镜肺叶切除术和完全淋巴结清扫术的患者的临床病理变量与 HNM 或 MNM 的相关性。在分析了这些变量后,我们使用列线图建立了多变量逻辑模型来估计不同区域淋巴结转移的风险。然后在 418 例验证队列中验证了预测效能。结果证实癌胚抗原(>5.75ng/mL)、细胞角蛋白 19 片段(>2.85ng/mL)、肿瘤最大直径(>2.75cm)、肿瘤分化程度(III 级)、支气管黏膜和软骨侵犯、血管侵犯是 HNM 的预测因子,癌胚抗原(>8.25ng/mL)、细胞角蛋白 19 片段(>2.95ng/mL)、肿瘤最大直径(>2.75cm)、肿瘤分化程度(III 级)、支气管黏膜和软骨侵犯、血管侵犯和内脏胸膜侵犯是 MNM 的预测因子。基于上述结果验证预测模型显示出良好的判别能力。我们的预测模型有助于为临床 I 期 NSCLC 患者的区域淋巴结转移制定特定的治疗策略。